KRAS G12C mutation

Clinical trials for KRAS G12C mutation explained in plain language.

Never miss a new study

Get alerted when new KRAS G12C mutation trials appear

Sign up with your email to follow new studies for KRAS G12C mutation, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 3 Completed 1

Can a pill target a common cancer mutation?

Disease control Completed

This early-stage trial is testing an experimental pill called BEBT-607 in adults with advanced or metastatic solid tumors that have a specific genetic change known as KRAS G12C. The study aims to find the safest dose and see whether the drug can shrink tumors or slow their growth…

Matched conditions: KRAS G12C MUTATION

Phase 1 • Sponsor: BeBetter Med Inc • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC

KRAS G12C mutation

Get alerted when new KRAS G12C mutation trials appear

Can a pill target a common cancer mutation?